Skip to content

Study on the Efficacy and Applications of Straw Phonation Training on Vocal Fatigue

Study on the Efficacy and Applications of Straw Phonation Training on Vocal Fatigue

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400087198
Enrollment
Unknown
Registered
2024-07-22
Start date
2024-07-23
Completion date
Unknown
Last updated
2024-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vocal Fatigue

Interventions

control group:vocal rest for 10 minutes
Experimental group A:Straw phonation training for 10 minutes
Experimental group B:vocal rest for 5 minutes and straw phonation training for 5 minutes

Sponsors

The Third Xiangya Hospital, Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: (1) The subjects are healthy adults aged 20 to 40 years old with a minimum education level of high school. (2) All subjects undergo laryngoscopic examination and show no organic lesions. (3) No smoking history. (4) No health issues caused by excessive alcohol consumption. (5) No history of voice complaints or voice disorders. (6) No acute infections within 2 weeks prior to participation in the study. (7) All participants provide informed consent prior to participation. (8) Participants are instructed to avoid excessive vocal use (e.g., singing, shouting, speaking loudly), spicy foods, carbonated or caffeinated beverages, and alcohol within 24 hours before and after participation. Additionally, they should not eat anything within 1 hour before the test to avoid throat reflux.

Exclusion criteria

Exclusion criteria: (1) Any organic pathology affecting the vocal cords. (2) Significant diseases of the respiratory, nervous, cardiovascular, and hepatic systems, as well as hearing impairments. (3) Individuals with cognitive impairments, psychiatric disorders, and conversion disorders. (4) Participants who do not comply with the trial protocol, thereby affecting the assessment of efficacy. (5) Participants who prematurely withdraw from the treatment due to severe adverse events or specific physiological abnormalities. (6) Missing relevant data that may impact the assessment of efficacy and safety.

Design outcomes

Primary

MeasureTime frame
Maximum phonation time;jitter;shimmer;HNR;cepstral peak prominence;Vocal Tract Discomfort Scale;

Secondary

MeasureTime frame
current speaking effort level;laryngeal discomfort;

Countries

China

Contacts

Public ContactJing Peng

The Third Xiangya Hospital, Central South University

pjing602578@csu.edu.cn+86 186 7007 3685

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 21, 2026